AD Pharma

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market 2017 Analysis, Share, Regional Outlook, Forecast : Global QYResearch

Press Release   •   Feb 16, 2017 10:51 EET

This report studies sales (consumption) of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
Tobira Therapeutics
Verva Pharmaceuticals
Zafgen

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India

Request more information at http://globalqyresearch.com/download-sample/165875 

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II

Split by applications, this report focuses on sales, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into
Application 1
Application 2

View full report at http://globalqyresearch.com/global-non-alcoholic-fatty-liver-disease-nafld-drug-sales-market-report-2017

Table of Contents

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2022)
1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Competition by Manufacturers, Type and Application
2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
2.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions
2.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
2.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
3.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
3.1.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
3.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
3.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
3.4 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
4.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
4.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

6 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
6.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
6.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
7 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application
8 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
8.1.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
8.1.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
8.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
9.1 Conatus Pharmaceuticals
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Daewoong Pharmaceutical
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Galmed International
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Kyorin Pharmaceutical
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Metabolic Solutions Development
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Novartis AG
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Phenex Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Raptor Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 TCM Biotech International
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Tobira Therapeutics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Verva Pharmaceuticals
9.12 Zafgen

10 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Maufacturing Cost Analysis
10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
10.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2022)
14.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price and Trend Forecast (2017-2022)
14.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/165875

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch